JP2008538183A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008538183A5 JP2008538183A5 JP2008504533A JP2008504533A JP2008538183A5 JP 2008538183 A5 JP2008538183 A5 JP 2008538183A5 JP 2008504533 A JP2008504533 A JP 2008504533A JP 2008504533 A JP2008504533 A JP 2008504533A JP 2008538183 A5 JP2008538183 A5 JP 2008538183A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- seq
- antibody
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical class 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 9
- 229920001184 polypeptide Polymers 0.000 claims 9
- 102000004965 antibodies Human genes 0.000 claims 5
- 108090001123 antibodies Proteins 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 206010027202 Meningitis bacterial Diseases 0.000 claims 2
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 2
- 201000009904 bacterial meningitis Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 241000606768 Haemophilus influenzae Species 0.000 claims 1
- 229940047650 Haemophilus influenzae Drugs 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102000005614 monoclonal antibodies Human genes 0.000 claims 1
- 108010045030 monoclonal antibodies Proteins 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 229960005486 vaccines Drugs 0.000 claims 1
Claims (18)
- 前記フラグメントが前記配列番号のアミノ酸配列由来のT細胞またはB細胞エピトープを
含む、請求項3に記載のポリペプチド。 - 請求項1〜4のいずれか1項に記載のポリペプチドに結合する、抗体。
- モノクローナル抗体である、請求項5に記載の抗体。
- 高いストリンジェンシーの条件下で、請求項8に記載の核酸にハイブリダイズし得る、核
酸。 - 請求項1〜4のいずれか1項に記載のポリペプチドをコードする、核酸。
- (a)請求項1〜11のいずれか1項に記載のポリペプチド、抗体および/または核酸と
、
(b)薬学的に受容可能なキャリアと
を含む、組成物。 - ワクチンアジュバントをさらに含む、請求項12に記載の組成物。
- 医薬としての使用のための、請求項1〜11のいずれか1項に記載の核酸、ポリペプチド
、または抗体。 - 患者を処置するための、請求項12に記載の組成物。
- インフルエンザ菌(Haemophilus influenzae)によって引き起こ
される疾患および/または感染を処置または予防するための医薬の製造における、請求項
1〜11のいずれか1項に記載の核酸、ポリペプチド、または抗体の使用。 - 細菌性髄膜炎を予防するための、請求項15に記載の組成物。
- 細菌性髄膜炎を予防するための、請求項16に記載の使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66792105P | 2005-03-30 | 2005-03-30 | |
PCT/US2006/012606 WO2006110413A2 (en) | 2005-03-30 | 2006-03-30 | Haemophilus influenzae type b |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008538183A JP2008538183A (ja) | 2008-10-16 |
JP2008538183A5 true JP2008538183A5 (ja) | 2009-05-14 |
Family
ID=37087506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008504533A Pending JP2008538183A (ja) | 2005-03-30 | 2006-03-30 | B型インフルエンザ菌 |
Country Status (11)
Country | Link |
---|---|
US (4) | US20100034822A1 (ja) |
EP (1) | EP1871888A4 (ja) |
JP (1) | JP2008538183A (ja) |
CN (1) | CN101687025A (ja) |
AU (1) | AU2006235045A1 (ja) |
BR (1) | BRPI0609460A2 (ja) |
CA (1) | CA2602665A1 (ja) |
MX (1) | MX2007012057A (ja) |
NZ (2) | NZ591415A (ja) |
RU (1) | RU2007139915A (ja) |
WO (1) | WO2006110413A2 (ja) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8647642B2 (en) | 2008-09-18 | 2014-02-11 | Aviex Technologies, Llc | Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment |
US9770463B2 (en) | 2010-07-06 | 2017-09-26 | Glaxosmithkline Biologicals Sa | Delivery of RNA to different cell types |
EP2590626B1 (en) | 2010-07-06 | 2015-10-28 | GlaxoSmithKline Biologicals SA | Liposomes with lipids having an advantageous pka-value for rna delivery |
PT2590676T (pt) | 2010-07-06 | 2016-11-04 | Glaxosmithkline Biologicals Sa | Partículas de transferência de tipo virião para moléculas de arn auto-replicante |
ES2646669T3 (es) | 2010-07-06 | 2017-12-14 | Glaxosmithkline Biologicals Sa | Procedimientos de aumento de una respuesta inmunitaria mediante el suministro de ARN |
WO2012006369A2 (en) | 2010-07-06 | 2012-01-12 | Novartis Ag | Immunisation of large mammals with low doses of rna |
EP3542789A3 (en) | 2010-08-31 | 2020-01-01 | GlaxoSmithKline Biologicals SA | Lipids suitable for liposomal delivery of protein-coding rna |
PL3981427T3 (pl) | 2010-08-31 | 2022-09-19 | Glaxosmithkline Biologicals S.A. | Pegylowane liposomy do dostarczania rna kodującego immunogen |
TR201903651T4 (tr) | 2010-10-11 | 2019-04-22 | Glaxosmithkline Biologicals Sa | Antijen uygulama platformları. |
EP2707024A4 (en) * | 2011-05-11 | 2015-03-04 | Riesbeck Healthcare Sweden Ab | PROTEIN F - A NEW HAEMOPHILUS INFLUENZAE ADHESINE WITH LAMININ AND VITRONECTIN BINDING CHARACTERISTICS |
CA2840989A1 (en) | 2011-07-06 | 2013-01-10 | Novartis Ag | Immunogenic combination compositions and uses thereof |
JP2014520806A (ja) | 2011-07-06 | 2014-08-25 | ノバルティス アーゲー | Rna分子の送達のための有用なn:p比を有するリポソーム |
SG10201602456WA (en) | 2011-08-31 | 2016-04-28 | Novartis Ag | Pegylated liposomes for delivery of immunogen-encoding rna |
AU2013320313B2 (en) | 2012-09-18 | 2018-07-12 | Glaxosmithkline Biologicals Sa | Outer membrane vesicles |
ES2887254T3 (es) | 2013-03-08 | 2021-12-22 | Novartis Ag | Lípidos y composiciones lipídicas para el suministro de agentes activos |
AR090303A1 (es) * | 2013-03-11 | 2014-11-05 | Consejo Nac Invest Cient Tec | Polipeptido mutado, cepa de bacterias que lo comprende y metodos para detectar diferentes cationes metalicos simultaneamente |
US9868777B2 (en) | 2013-06-10 | 2018-01-16 | Merck Sharp & Dohme Corp. | CMV neutralizing antigen binding proteins |
WO2015095346A1 (en) | 2013-12-19 | 2015-06-25 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
ES2774968T3 (es) | 2013-12-19 | 2020-07-23 | Novartis Ag | Lípidos y composiciones lipídicas para la administración de agentes activos |
ES2949172T3 (es) | 2014-07-16 | 2023-09-26 | Novartis Ag | Método de encapsulamiento de un ácido nucleico en un hospedante de nanopartículas lipídicas |
WO2016037053A1 (en) | 2014-09-05 | 2016-03-10 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
EP3061826A1 (en) | 2015-02-27 | 2016-08-31 | Novartis AG | Flavivirus replicons |
GB201508860D0 (en) | 2015-05-22 | 2015-07-01 | Nat Univ Ireland | Diagnostic method |
US11401520B2 (en) | 2016-10-21 | 2022-08-02 | The Research Foundation For The State University Of New York | Compositions and methods comprising permuted protein tags for facilitating overexpression, solubility, and purification of target proteins |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
GB2599573A (en) * | 2019-05-31 | 2022-04-06 | Rhogen Biotech Llc | Compositions and methods for detoxifying bacterial endotoxins |
US11357845B2 (en) * | 2019-07-08 | 2022-06-14 | The Trustees Of The University Of Pennsylvania | Protein antigens for vaccinating against nontypeable Haemophilus influenzae |
EP4237577A1 (en) * | 2020-10-30 | 2023-09-06 | Gen-Probe Incorporated | Compositions and methods for detecting influenza a, influenza b, and sars-cov-2 |
EP4387597A1 (en) | 2021-08-16 | 2024-06-26 | GlaxoSmithKline Biologicals SA | Freeze-drying of lipid nanoparticles (lnps) encapsulating rna and formulations thereof |
EP4387596A1 (en) | 2021-08-16 | 2024-06-26 | GlaxoSmithKline Biologicals SA | Low-dose lyophilized rna vaccines and methods for preparing and using the same |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6355450B1 (en) * | 1995-04-21 | 2002-03-12 | Human Genome Sciences, Inc. | Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof |
GB9513074D0 (en) * | 1995-06-27 | 1995-08-30 | Cortecs Ltd | Novel anigen |
US6593114B1 (en) * | 1996-01-05 | 2003-07-15 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
US6914131B1 (en) * | 1998-10-09 | 2005-07-05 | Chiron S.R.L. | Neisserial antigens |
US6730827B1 (en) * | 1998-07-14 | 2004-05-04 | E. I. Du Pont De Nemours And Company | Genes encoding plant adenosine 5′-phosphosulfate reductase |
US7365185B2 (en) * | 2000-07-19 | 2008-04-29 | Monsanto Technology Llc | Genomic plant sequences and uses thereof |
CA2404260A1 (en) * | 2000-03-21 | 2001-09-27 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in prokaryotes |
US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
US6936585B2 (en) * | 2002-01-16 | 2005-08-30 | The Procter & Gamble Company | Corticotropin releasing factor 2 receptor agonists |
WO2004078949A2 (en) * | 2003-03-06 | 2004-09-16 | Children's Hospital, Inc. | Genes of an otitis media isolate of nontypeable haemophilus influenzae |
GB0315022D0 (en) * | 2003-06-26 | 2003-07-30 | Chiron Srl | Virulence-associated adhesins |
GB0410866D0 (en) * | 2004-05-14 | 2004-06-16 | Chiron Srl | Haemophilius influenzae |
EP1899366A2 (en) * | 2005-06-16 | 2008-03-19 | Children's Hospital, Inc. | Genes of an otitis media isolate of nontypeable haemophilus influenzae |
-
2006
- 2006-03-30 EP EP06758272.6A patent/EP1871888A4/en not_active Withdrawn
- 2006-03-30 US US11/887,712 patent/US20100034822A1/en not_active Abandoned
- 2006-03-30 NZ NZ591415A patent/NZ591415A/xx not_active IP Right Cessation
- 2006-03-30 WO PCT/US2006/012606 patent/WO2006110413A2/en active Application Filing
- 2006-03-30 RU RU2007139915/13A patent/RU2007139915A/ru not_active Application Discontinuation
- 2006-03-30 MX MX2007012057A patent/MX2007012057A/es unknown
- 2006-03-30 AU AU2006235045A patent/AU2006235045A1/en not_active Abandoned
- 2006-03-30 NZ NZ562381A patent/NZ562381A/en not_active IP Right Cessation
- 2006-03-30 JP JP2008504533A patent/JP2008538183A/ja active Pending
- 2006-03-30 CA CA002602665A patent/CA2602665A1/en not_active Abandoned
- 2006-03-30 CN CN200680018203A patent/CN101687025A/zh active Pending
- 2006-03-30 BR BRPI0609460-0A patent/BRPI0609460A2/pt not_active IP Right Cessation
-
2011
- 2011-12-21 US US13/333,815 patent/US20120093868A1/en not_active Abandoned
-
2014
- 2014-06-19 US US14/309,829 patent/US20140302078A1/en not_active Abandoned
-
2015
- 2015-10-06 US US14/876,623 patent/US20160024157A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2008538183A5 (ja) | ||
JP2008525033A5 (ja) | ||
RU2007139915A (ru) | Haemophilus influenzae типа в | |
JP2010166916A5 (ja) | ||
JP2012000112A5 (ja) | ||
RU2006144093A (ru) | Полипептиды нетипируемой haemophilus influenzae | |
JP2008529558A5 (ja) | ||
JP2003527079A5 (ja) | ||
JP2011004753A5 (ja) | ||
JP2008508859A5 (ja) | ||
JP2010273685A5 (ja) | ||
RU2009102815A (ru) | Полипептиды из neisseria meningitidis | |
JP2005511076A5 (ja) | ||
JP2002531129A5 (ja) | ||
JP2017507181A5 (ja) | ||
JP2002542827A5 (ja) | ||
JP2012522010A5 (ja) | ||
JP2007502101A5 (ja) | ||
EP2292648A3 (en) | Small Streptococcus pyogenes antigens and their use | |
JP2015514132A5 (ja) | ||
JP2010532657A5 (ja) | ||
JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
JP2012515557A5 (ja) | ||
JP2010508276A5 (ja) | ||
JP2004531242A5 (ja) |